LYNNAIRE JASTILLANO: Open Payments
NPI 1235685421 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 107 payments from 18 companies in 2025. Trend: 2023 $1,321 · 2024 $1,870 · 2025 $2,235
Food & beverage: $2,179Education: $56
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $219 |
| Fresenius USA Marketing, Inc. | 10 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $197 |
| Amgen Inc. | 13 | $179 |
| Novo Nordisk Inc | 7 | $155 |
| Calliditas Therapeutics US Inc. | 5 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Travere Therapeutics, Inc. | 5 | $131 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
| ANI Pharmaceuticals, Inc. | 4 | $127 |
Products named: VELPHORO, Kerendia, JYNARQUE, JARDIANCE, TARPEYO, FARXIGA, PURIFIED CORTROPHIN GEL, KRYSTEXXA.
Industry payments across IN — which companies pay providers there.
